Literature DB >> 18360040

Haplotype-based case-control study of estrogen receptor alpha (ESR1) gene and pregnancy-induced hypertension.

Masaaki Tamura1, Tomohiro Nakayama, Ichiro Sato, Naoyuki Sato, Noriko Izawa, Mikano Hishiki, Yoshihiro Mizutani, Kiyohide Furuya, Tatsuo Yamamoto.   

Abstract

Hypotheses about pregnancy-induced hypertension (PIH) have been proposed to explain the vascular damage that characterizes this disease. Reports indicate that estrogens and estrogen receptors play important physiological roles in cardiovascular diseases. There have been studies examining the association between coronary artery disease and the estrogen receptor alpha (ESR1) gene. The aim of the present work was to assess the association between PIH and single-nucleotide polymorphisms (SNPs) in the human ESR1 gene, by conducting a haplotype-based case-control study. Based on a database search at the web site of the National Center of Biotechnology Information, we chose five SNPs in the human ESR1 gene, and performed an association study using 95 PIH patients and 200 age-matched non-PIH subjects. The frequency of rs2881766 genotypes and alleles differed significantly between the two groups. There was no significant difference in overall distribution of genotypes or alleles of the other four SNPs. The T allele of rs2881766 was significantly more prevalent in the PIH group than in the non-PIH group. Haplotype-based case-control analysis revealed that there was a significant difference in overall distribution of the combinations rs2881766-rs1643821-rs988328 and rs2881766-rs1643821 between the PIH group and the non-PIH group (all or body mass index [BMI]-matched). One susceptibility haplotype for PIH and two resistance haplotypes for PIH were revealed by comparison between the PIH group and the non-PIH (BMI-matched) control group. In conclusion, the T allele of rs2881766 could be a useful genetic marker of PIH. The G-A-T haplotype of rs2881766-rs1643821-rs988328 and the G-A haplotype of rs2881766-rs1643821 appear to be resistance markers of PIH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360040     DOI: 10.1291/hypres.31.221

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  5 in total

1.  Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria.

Authors:  Jutta Pretscher; Matthias Ruebner; Arif B Ekici; Melanie Rödl; Hanna Huebner; Judith Schwitulla; Adriana Titzmann; Charlotte Hartwig; Matthias W Beckmann; Peter A Fasching; Michael O Schneider; Eva Schwenke
Journal:  Arch Gynecol Obstet       Date:  2020-09-30       Impact factor: 2.344

2.  Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.

Authors:  Masanori Shimodaira; Tomohiro Nakayama; Ichiro Sato; Naoyuki Sato; Noriko Izawa; Yoshihiro Mizutani; Kiyohide Furuya; Tatsuo Yamamoto
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

3.  Analysis of sex hormone genes reveals gender differences in the genetic etiology of blood pressure salt sensitivity: the GenSalt study.

Authors:  Tanika N Kelly; Casey M Rebholz; Dongfeng Gu; James E Hixson; Treva K Rice; Jie Cao; Jichun Chen; Jianxin Li; Fanghong Lu; Jixiang Ma; Jianjun Mu; Paul K Whelton; Jiang He
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

4.  Estrogen Receptor Alpha (ESR1) Gene Polymorphisms in Pre-eclamptic Saudi Patients.

Authors:  Hesham A El-Beshbishy; Manal A Tawfeek; Nevin M Al-Azhary; Reham A Mariah; Fawzia A Habib; Lamya Aljayar; Abrar F Alahmadi
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

5.  SRC-1 Regulates Blood Pressure and Aortic Stiffness in Female Mice.

Authors:  Antentor Othrell Hinton; Yongjie Yang; Ann P Quick; Pingwen Xu; Chitra L Reddy; Xiaofeng Yan; Corey L Reynolds; Qingchun Tong; Liangru Zhu; Jianming Xu; Xander H T Wehrens; Yong Xu; Anilkumar K Reddy
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.